COST ANALYSIS OF SCREENING ACCORDING TO ECCO GUIDELINES FOR PREVENTION OF OPPORTUNISTIC INFECTIONS IN INFLIXIMAB-TREATED IBD PATIENTS

被引：1
|
作者：
Metz, A. [1 ]
Elliott, T. [2 ]
Hull, B. [2 ]
Duncan, J. [2 ]
Sastrillo, M. [2 ]
Smith, M. [2 ]
Sanderson, J. D. [2 ]
Irving, P. M. [2 ]
机构：
[1] Addenbrookes Hosp, Cambridge, England
[2] Guys & St Thomas Hosp, London SE1 9RT, England
来源：
GUT | 2011年 / 60卷
关键词：
D O I：
10.1136/gut.2011.239301.301
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A142 / A142
页数：1
相关论文
共 50 条
  • [31] Cost effectiveness analysis of screening for advanced hepatic fibrosis in patients with various 'at-risk population' in guidelines
    Kim, Hye-Lin
    Park, Huiyul
    Lee, Hyo Young
    Yoon, Eileen
    Kim, Mimi
    Ahn, Sang Bong
    Lee, Chul-min
    Kang, Bo-Kyeong
    Sohn, Joo Hyun
    An, Jihyun
    Oh, Joo Hyun
    Jun, Dae Won
    Jang, Eun Chul
    JOURNAL OF HEPATOLOGY, 2023, 78 : S667 - S667
  • [32] The incidence of opportunistic infections in patients with psoriatic arthritis treated with biologic and targeted synthetic agents: A systematic review and meta-analysis
    Vassilopoulos, Athanasios
    Shehadeh, Fadi
    Benitez, Gregorio
    Kalligeros, Markos
    Cunha, Joanne S.
    Cunha, Cheston B.
    Mylonakis, Eleftherios
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] Prevention of gram-positive infections in peritoneal dialysis patients in Hong Kong: A cost-effectiveness analysis
    Wong, Carlos
    Luk, In-wa
    Ip, Margaret
    You, Joyce H. S.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (04) : 412 - 416
  • [34] COST ANALYSIS OF TWO TREATMENTS BY INFLIXIMAB (ORIGINATOR AND BIOSIMILAR) FOR PATIENTS WITH RHUMATOID ARTHRITIS (RA) OR INFLAMMATORY BOWEL DISEASE (IBD) IN A GROUP OF FRENCH PUBLIC HOSPITALS (UNIHA)
    Moreau, Petiteau F.
    Hadjadj, C.
    Feuillerat, M.
    VALUE IN HEALTH, 2020, 23 : S16 - S16
  • [35] Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Olivera, Pablo A.
    Lasa, Juan S.
    Zubiaurre, Ignacio
    Jairath, Vipul
    Abreu, Maria T.
    Rubin, David T.
    Reinisch, Walter
    Magro, Fernando
    Rahier, Jean-Francois
    Danese, Silvio
    Rabaud, Christian
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (02) : 199 - 210
  • [36] Early Antiretroviral Therapy for Patients With Acute AIDS-Related Opportunistic Infections: A Cost-Effectiveness Analysis of ACTG A5164
    Sax, Paul E.
    Sloan, Caroline E.
    Schackman, Bruce R.
    Grant, Philip M.
    Rong, Jian
    Zolopa, Andrew R.
    Powderly, William
    Losina, Elena
    Freedberg, Kenneth A.
    HIV CLINICAL TRIALS, 2010, 11 (05): : 248 - 259
  • [37] COST OF DIABETIC FOOT INFECTIONS DUE TO MRSA: AN ECONOMIC ANALYSIS OF DATA FROM PATIENTS TREATED WITH LINEZOLID IN SPAIN
    Zaragoza, R.
    Garcia, M.
    Blanes, L.
    Flores, J.
    Chacon, A.
    Hernandez, F.
    Escudero, E.
    VALUE IN HEALTH, 2009, 12 (07) : A422 - A422
  • [38] COST ANALYSIS OF SEVERE HYPOGLYCEMIA IN TREATED TYPE 2 DIABETIC PATIENTS ACCORDING TO ANTI-HYPERGLYCEMIC AGENT THERAPY
    Laires, P.
    Conceicao, J.
    Dores, J.
    Araujo, F.
    Silva, C.
    Radican, L.
    Nogueira, A. M.
    VALUE IN HEALTH, 2014, 17 (07) : A352 - A353
  • [39] SINGLE CENTRE COMPARISON OF MORTALITY, HOSPITAL RECORDED SERIOUS ADVERSE EVENTS (SAE) AND PRIMARY CARE RECORDED OPPORTUNISTIC INFECTIONS (OI) IN IBD PATIENTS TREATED WITH ANTI-TNF COMPARED TO THIOPURINES ALONE
    Waters, O.
    Saunders, M.
    Bulsara, M.
    Ahmad, T.
    GUT, 2012, 61 : A392 - A393
  • [40] Consensus of infectious complications in patients treated with selected biological therapies. Second part: Chilean Guidelines for Prevention of Infections associated to use of Biological Therapies (PREVITEB)
    Ceron, Ines
    Vizcaya, Cecilia
    Gambra, Pilar
    Ferres, Marcela
    Bidart, Teresa
    Lopez, Tania
    Paz Acuna, Maria
    Maria Alvarez, Ana
    Zubieta, Marcela
    Rabello, Marcela
    Duran, Luisa
    Rabagliati, Ricardo
    REVISTA CHILENA DE INFECTOLOGIA, 2019, 36 (05): : 616 - 628
12345